Evidence map›Paper›PMID 26973513›Full record

ArticleFrontiers in aging neuroscience2016

Effects of Omega-3 Fatty Acid Supplementation on Cognitive Functions and Neural Substrates: A Voxel-Based Morphometry Study in Aged Mice.

Debora Cutuli, Marco Pagani, Paola Caporali, Alberto Galbusera, Daniela Laricchiuta, Francesca Foti, Cristina Neri, Gianfranco Spalletta, Carlo Caltagirone, Laura Petrosini and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The Potential Neuroprotective Effect ofMolecules (Basel, Switzerland) · 2022
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Debora CutuliSanta Lucia FoundationRome, Italy; University of Rome "Sapienza"Rome, Italy.
Marco PaganiFunctional Neuroimaging Laboratory, Istituto Italiano di TecnologiaRovereto, Italy; Center for Mind and Brain Sciences, University of TrentoRovereto, Italy.
Paola CaporaliSanta Lucia FoundationRome, Italy; University of Rome "Sapienza"Rome, Italy.
Alberto GalbuseraFunctional Neuroimaging Laboratory, Istituto Italiano di Tecnologia Rovereto, Italy.
Daniela LaricchiutaSanta Lucia FoundationRome, Italy; University of Rome "Sapienza"Rome, Italy.
Francesca FotiSanta Lucia FoundationRome, Italy; University of Rome "Sapienza"Rome, Italy.
Cristina NeriSanta Lucia Foundation Rome, Italy.
Gianfranco SpallettaSanta Lucia Foundation Rome, Italy.
Carlo CaltagironeSanta Lucia FoundationRome, Italy; University of Rome "Tor Vergata"Rome, Italy.
Laura PetrosiniSanta Lucia FoundationRome, Italy; University of Rome "Sapienza"Rome, Italy.
Alessandro GozziFunctional Neuroimaging Laboratory, Istituto Italiano di Tecnologia Rovereto, Italy.
Fondazione Santa Lucia · ITSapienza University of Rome · ITItalian Institute of Technology · ITCenter for Neuroscience and Cognitive Systems · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human and experimental studies have revealed putative neuroprotective and pro-cognitive effects of omega-3 polyunsaturated fatty acids (n-3 PUFA) in aging, evidencing positive correlations between peripheral n-3 PUFA levels and regional grey matter (GM) volume, as well as negative correlations between dietary n-3 PUFA levels and cognitive deficits. We recently showed that n-3 PUFA supplemented aged mice exhibit better hippocampal-dependent mnesic functions, along with enhanced cellular plasticity and reduced neurodegeneration, thus supporting a role of n-3 PUFA supplementation in preventing cognitive decline during aging. To corroborate these initial results and develop new evidence on the effects of n-3 PUFA supplementation on brain substrates at macro-scale level, here we expanded behavioral analyses to the emotional domain (anxiety and coping skills), and carried out a fine-grained regional GM volumetric mapping by using high-resolution MRI-based voxel-based morphometry. The behavioral effects of 8 week n-3 PUFA supplementation were measured on cognitive (discriminative, spatial and social) and emotional (anxiety and coping) abilities of aged (19 month-old at the onset of study) C57B6/J mice. n-3 PUFA supplemented mice showed better mnesic performances as well as increased active coping skills. Importantly, these effects were associated with enlarged regional hippocampal, retrosplenial and prefrontal GM volumes, and with increased post mortem n-3 PUFA brain levels. These findings indicate that increased dietary n-3 PUFA intake in normal aging can improve fronto-hippocampal GM structure and function, an effect present also when the supplementation starts at late age. Our data are consistent with a protective role of n-3 PUFA supplementation in counteracting cognitive decline, emotional dysfunctions and brain atrophy.

Indexed as

agingcognitive declinedietary supplementationMRIomega-3 fatty acidsvoxel-based morphometry

Identifiers

PMID26973513
PMCPMC4777728
OpenAlexW2328824025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.